<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p212" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_212{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_212{left:306px;bottom:30px;}
#t3_212{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_212{left:346px;bottom:30px;}
#t5_212{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_212{left:517px;bottom:30px;}
#t7_212{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_212{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_212{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_212{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_212{left:35px;bottom:777px;letter-spacing:0.12px;word-spacing:0.06px;}
#tc_212{left:35px;bottom:759px;letter-spacing:0.11px;word-spacing:0.08px;}
#td_212{left:35px;bottom:739px;letter-spacing:0.16px;}
#te_212{left:396px;bottom:739px;}
#tf_212{left:35px;bottom:702px;letter-spacing:0.17px;word-spacing:0.02px;}
#tg_212{left:35px;bottom:683px;letter-spacing:0.14px;word-spacing:0.04px;}
#th_212{left:35px;bottom:665px;letter-spacing:0.07px;word-spacing:0.12px;}
#ti_212{left:35px;bottom:645px;letter-spacing:0.11px;word-spacing:0.08px;}
#tj_212{left:35px;bottom:625px;letter-spacing:-0.23px;word-spacing:1.63px;}
#tk_212{left:132px;bottom:625px;letter-spacing:0.16px;}
#tl_212{left:493px;bottom:625px;}
#tm_212{left:35px;bottom:589px;letter-spacing:0.06px;word-spacing:-0.66px;}
#tn_212{left:35px;bottom:570px;letter-spacing:0.04px;word-spacing:0.15px;}
#to_212{left:35px;bottom:551px;letter-spacing:0.09px;word-spacing:0.09px;}
#tp_212{left:35px;bottom:531px;letter-spacing:0.1px;word-spacing:0.09px;}
#tq_212{left:35px;bottom:512px;letter-spacing:0.16px;}
#tr_212{left:405px;bottom:512px;}
#ts_212{left:35px;bottom:476px;letter-spacing:0.04px;word-spacing:0.15px;}
#tt_212{left:35px;bottom:457px;letter-spacing:0.11px;word-spacing:0.08px;}
#tu_212{left:35px;bottom:437px;letter-spacing:0.04px;word-spacing:0.14px;}
#tv_212{left:35px;bottom:418px;letter-spacing:0.04px;word-spacing:0.15px;}
#tw_212{left:35px;bottom:398px;letter-spacing:0.16px;}
#tx_212{left:386px;bottom:398px;}
#ty_212{left:35px;bottom:363px;letter-spacing:0.07px;word-spacing:-0.83px;}
#tz_212{left:35px;bottom:343px;letter-spacing:0.08px;word-spacing:0.11px;}
#t10_212{left:35px;bottom:324px;letter-spacing:0.08px;word-spacing:0.1px;}
#t11_212{left:35px;bottom:304px;letter-spacing:0.05px;word-spacing:0.14px;}
#t12_212{left:35px;bottom:284px;letter-spacing:0.16px;}
#t13_212{left:405px;bottom:284px;}
#t14_212{left:35px;bottom:249px;letter-spacing:-0.02px;word-spacing:-0.41px;}
#t15_212{left:35px;bottom:229px;letter-spacing:0.06px;word-spacing:0.13px;}
#t16_212{left:35px;bottom:210px;letter-spacing:0.15px;word-spacing:0.04px;}
#t17_212{left:35px;bottom:190px;letter-spacing:0.1px;word-spacing:0.09px;}
#t18_212{left:35px;bottom:171px;letter-spacing:0.16px;}
#t19_212{left:405px;bottom:171px;}
#t1a_212{left:35px;bottom:135px;letter-spacing:-0.01px;word-spacing:0.2px;}
#t1b_212{left:35px;bottom:116px;letter-spacing:0.01px;word-spacing:0.31px;}
#t1c_212{left:35px;bottom:96px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1d_212{left:35px;bottom:77px;letter-spacing:0.16px;}
#t1e_212{left:405px;bottom:77px;}
#t1f_212{left:618px;bottom:777px;letter-spacing:0.12px;word-spacing:-0.69px;}
#t1g_212{left:618px;bottom:759px;letter-spacing:0.04px;word-spacing:0.15px;}
#t1h_212{left:618px;bottom:739px;letter-spacing:-0.04px;word-spacing:0.23px;}
#t1i_212{left:618px;bottom:720px;letter-spacing:0.01px;word-spacing:-0.83px;}
#t1j_212{left:618px;bottom:700px;letter-spacing:0.05px;word-spacing:0.15px;}
#t1k_212{left:618px;bottom:680px;letter-spacing:0.02px;word-spacing:-0.89px;}
#t1l_212{left:618px;bottom:661px;letter-spacing:-0.13px;word-spacing:0.31px;}
#t1m_212{left:743px;bottom:661px;letter-spacing:0.16px;}
#t1n_212{left:1112px;bottom:661px;}
#t1o_212{left:618px;bottom:625px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1p_212{left:618px;bottom:606px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1q_212{left:618px;bottom:586px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1r_212{left:618px;bottom:567px;letter-spacing:0.16px;}
#t1s_212{left:988px;bottom:567px;}
#t1t_212{left:618px;bottom:531px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1u_212{left:618px;bottom:512px;letter-spacing:0.01px;word-spacing:-0.2px;}
#t1v_212{left:618px;bottom:492px;letter-spacing:0.03px;word-spacing:0.36px;}
#t1w_212{left:618px;bottom:473px;letter-spacing:0.16px;}
#t1x_212{left:979px;bottom:473px;}
#t1y_212{left:618px;bottom:437px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1z_212{left:618px;bottom:418px;letter-spacing:0.08px;word-spacing:0.11px;}
#t20_212{left:618px;bottom:398px;letter-spacing:0.11px;word-spacing:0.07px;}
#t21_212{left:618px;bottom:379px;letter-spacing:0.08px;word-spacing:0.1px;}
#t22_212{left:618px;bottom:359px;letter-spacing:0.16px;}
#t23_212{left:979px;bottom:359px;}
#t24_212{left:618px;bottom:324px;letter-spacing:0.11px;word-spacing:0.08px;}
#t25_212{left:618px;bottom:304px;letter-spacing:0.1px;word-spacing:0.09px;}
#t26_212{left:618px;bottom:284px;letter-spacing:0.09px;word-spacing:0.09px;}
#t27_212{left:618px;bottom:265px;letter-spacing:0.16px;}
#t28_212{left:979px;bottom:265px;}
#t29_212{left:618px;bottom:229px;letter-spacing:-0.01px;word-spacing:-0.47px;}
#t2a_212{left:618px;bottom:210px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2b_212{left:618px;bottom:190px;letter-spacing:0.07px;word-spacing:0.11px;}
#t2c_212{left:618px;bottom:172px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2d_212{left:618px;bottom:152px;letter-spacing:0.06px;word-spacing:0.12px;}
#t2e_212{left:618px;bottom:133px;letter-spacing:0.16px;}
#t2f_212{left:979px;bottom:133px;}
#t2g_212{left:618px;bottom:96px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2h_212{left:618px;bottom:78px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2i_212{left:618px;bottom:58px;letter-spacing:0.06px;word-spacing:0.13px;}
#t2j_212{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_212{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_212{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_212{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_212{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_212{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_212{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_212{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts212" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg212Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg212" style="-webkit-user-select: none;"><object width="1210" height="935" data="212/212.svg" type="image/svg+xml" id="pdf212" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_212" class="t s0_212">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_212" class="t s1_212">© </span>
<span id="t3_212" class="t s0_212">(NCCN </span>
<span id="t4_212" class="t s1_212">© </span>
<span id="t5_212" class="t s0_212">), All rights reserved. NCCN Guidelines </span>
<span id="t6_212" class="t s1_212">® </span>
<span id="t7_212" class="t s0_212">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_212" class="t s2_212">NCCN Guidelines Version 4.2024 </span>
<span id="t9_212" class="t s2_212">Head and Neck Cancers </span>
<span id="ta_212" class="t s3_212">MS-71 </span>
<span id="tb_212" class="t s4_212">postoperative radiation plus chemotherapy trials of the EORTC (#22931) </span>
<span id="tc_212" class="t s4_212">and RTOG (# 9501). Head Neck 2005;27:843-850. Available at: </span>
<span id="td_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/16161069</span><span id="te_212" class="t s4_212">. </span>
<span id="tf_212" class="t s4_212">137. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the </span>
<span id="tg_212" class="t s4_212">RTOG 9501/intergroup phase III trial: postoperative concurrent radiation </span>
<span id="th_212" class="t s4_212">therapy and chemotherapy in high-risk squamous cell carcinoma of the </span>
<span id="ti_212" class="t s4_212">head and neck. Int J Radiat Oncol Biol Phys 2012;84:1198-1205. </span>
<span id="tj_212" class="t s4_212">Available at: </span><span id="tk_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/22749632</span><span id="tl_212" class="t s4_212">. </span>
<span id="tm_212" class="t s4_212">138. Noronha V, Joshi A, Patil VM, et al. Once-a-week versus once-every- </span>
<span id="tn_212" class="t s4_212">3-weeks cisplatin chemoradiation for locally advanced head and neck </span>
<span id="to_212" class="t s4_212">cancer: a phase III randomized noninferiority trial. J Clin Oncol </span>
<span id="tp_212" class="t s4_212">2018;36:1064-1072. Available at: </span>
<span id="tq_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/29220295</span><span id="tr_212" class="t s4_212">. </span>
<span id="ts_212" class="t s4_212">139. Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined </span>
<span id="tt_212" class="t s4_212">postoperative radiotherapy and weekly cisplatin infusion for locally </span>
<span id="tu_212" class="t s4_212">advanced head and neck carcinoma: final report of a randomized trial. Int </span>
<span id="tv_212" class="t s4_212">J Radiat Oncol Biol Phys 1996;36:999-1004. Available at: </span>
<span id="tw_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/8985019</span><span id="tx_212" class="t s4_212">. </span>
<span id="ty_212" class="t s4_212">140. Patil VM, Noronha V, Menon N, et al. Results of phase III randomized </span>
<span id="tz_212" class="t s4_212">trial for use of docetaxel as a radiosensitizer in patients with head and </span>
<span id="t10_212" class="t s4_212">neck cancer, unsuitable for cisplatin-based chemoradiation. J Clin Oncol </span>
<span id="t11_212" class="t s4_212">2023:JCO2200980. Available at: </span>
<span id="t12_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/36706347</span><span id="t13_212" class="t s4_212">. </span>
<span id="t14_212" class="t s4_212">141. Harari PM, Harris J, Kies MS, et al. Postoperative chemoradiotherapy </span>
<span id="t15_212" class="t s4_212">and cetuximab for high-risk squamous cell carcinoma of the head and </span>
<span id="t16_212" class="t s4_212">neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol </span>
<span id="t17_212" class="t s4_212">2014;32:2486-2495. Available at: </span>
<span id="t18_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/25002723</span><span id="t19_212" class="t s4_212">. </span>
<span id="t1a_212" class="t s4_212">142. Hasan Z, Dwivedi RC, Gunaratne DA, et al. Systematic review and </span>
<span id="t1b_212" class="t s4_212">meta-analysis of the complications of salvage total laryngectomy. Eur J </span>
<span id="t1c_212" class="t s4_212">Surg Oncol 2017;43:42-51. Available at: </span>
<span id="t1d_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/27265037</span><span id="t1e_212" class="t s4_212">. </span>
<span id="t1f_212" class="t s4_212">143. Gregoire V, Evans M, Le QT, et al. Delineation of the primary tumour </span>
<span id="t1g_212" class="t s4_212">clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, </span>
<span id="t1h_212" class="t s4_212">oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, </span>
<span id="t1i_212" class="t s4_212">DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, </span>
<span id="t1j_212" class="t s4_212">LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, </span>
<span id="t1k_212" class="t s4_212">SRO, SSHNO, TROG consensus guidelines. Radiother Oncol 2018;126:3- </span>
<span id="t1l_212" class="t s4_212">24. Available at: </span><span id="t1m_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/29180076</span><span id="t1n_212" class="t s4_212">. </span>
<span id="t1o_212" class="t s4_212">144. Lee AW, Ng WT, Pan JJ, et al. International guideline for the </span>
<span id="t1p_212" class="t s4_212">delineation of the clinical target volumes (CTV) for nasopharyngeal </span>
<span id="t1q_212" class="t s4_212">carcinoma. Radiother Oncol 2018;126:25-36. Available at: </span>
<span id="t1r_212" class="t s5_212">https://www.ncbi.nlm.nih.gov/pubmed/29153464</span><span id="t1s_212" class="t s4_212">. </span>
<span id="t1t_212" class="t s4_212">145. Stevens CM, Huang SH, Fung S, et al. Retrospective study of </span>
<span id="t1u_212" class="t s4_212">palliative radiotherapy in newly diagnosed head and neck carcinoma. Int J </span>
<span id="t1v_212" class="t s4_212">Radiat Oncol Biol Phys 2011;81:958-963. Available at: </span>
<span id="t1w_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/20950952</span><span id="t1x_212" class="t s4_212">. </span>
<span id="t1y_212" class="t s4_212">146. Porceddu SV, Rosser B, Burmeister BH, et al. Hypofractionated </span>
<span id="t1z_212" class="t s4_212">radiotherapy for the palliation of advanced head and neck cancer in </span>
<span id="t20_212" class="t s4_212">patients unsuitable for curative treatment--"Hypo Trial". Radiother Oncol </span>
<span id="t21_212" class="t s4_212">2007;85:456-462. Available at: </span>
<span id="t22_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/18036689</span><span id="t23_212" class="t s4_212">. </span>
<span id="t24_212" class="t s4_212">147. Corry J, Peters LJ, Costa ID, et al. The 'QUAD SHOT'--a phase II </span>
<span id="t25_212" class="t s4_212">study of palliative radiotherapy for incurable head and neck cancer. </span>
<span id="t26_212" class="t s4_212">Radiother Oncol 2005;77:137-142. Available at: </span>
<span id="t27_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/16260054</span><span id="t28_212" class="t s4_212">. </span>
<span id="t29_212" class="t s4_212">148. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group </span>
<span id="t2a_212" class="t s4_212">(RTOG) phase III randomized study to compare hyperfractionation and </span>
<span id="t2b_212" class="t s4_212">two variants of accelerated fractionation to standard fractionation </span>
<span id="t2c_212" class="t s4_212">radiotherapy for head and neck squamous cell carcinomas: first report of </span>
<span id="t2d_212" class="t s4_212">RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16. Available at: </span>
<span id="t2e_212" class="t s5_212">http://www.ncbi.nlm.nih.gov/pubmed/10924966</span><span id="t2f_212" class="t s4_212">. </span>
<span id="t2g_212" class="t s4_212">149. Beitler JJ, Zhang Q, Fu KK, et al. Final results of local-regional </span>
<span id="t2h_212" class="t s4_212">control and late toxicity of RTOG 9003: a randomized trial of altered </span>
<span id="t2i_212" class="t s4_212">fractionation radiation for locally advanced head and neck cancer. Int J </span>
<span id="t2j_212" class="t s6_212">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
